Cargando…
Serum Levels of Kisspeptin Are Elevated in Patients with Pancreatic Cancer
Pancreatic adenocarcinoma (PDAC) still represents a devastating disease associated with a very limited survival. Novel biomarkers allowing an early diagnosis as well as an optimal selection of suitable treatment options for individual patients are urgently needed to improve the dismal outcome of PDA...
Autores principales: | Loosen, Sven H., Luedde, Mark, Lurje, Georg, Spehlmann, Martina, Paffenholz, Pia, Ulmer, Tom Florian, Tacke, Frank, Vucur, Mihael, Trautwein, Christian, Neumann, Ulf P., Luedde, Tom, Roderburg, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854939/ https://www.ncbi.nlm.nih.gov/pubmed/31772690 http://dx.doi.org/10.1155/2019/5603474 |
Ejemplares similares
-
Serum levels of kisspeptin are elevated in critically ill patients
por: Luedde, Mark, et al.
Publicado: (2018) -
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019) -
Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019) -
A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)